1062 Repeat MRgFUS Thalamotomy for Recurrent Tremor: A Single-Center Study of Long-Term Efficacy and Durability
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: MRI-guided focused ultrasound (MRgFUS) thalamotomy is an incisionless, FDA-approved treatment for patients with medication-refractory essential tremor (ET) and tremor-dominant Parkinson’s Disease (TDPD). However, >10%–20% experience tremor recurrence and may be candidates for re-treatment. METHODS: This cohort includes all ET and TDPD patients undergoing repeat MRgFUS thalamotomy at a single-center (August 2016-March 2025). Unilateral MRgFUS thalamotomy was performed in standard fashion. TSs and SEs were determined prospectively using the Fahn-Tolosa-Marin (FTM) scale and a structured clinical SE questionnaire. Follow-up visits were conducted at 1-day and virtually at 1-week, 1-month, 3-months, 1-year, and annually thereafter. RESULTS: Twenty-six patients (mean age 76 ± 5 years; 69% male) with ET (n = 23) and TDPD (n = 3) underwent repeat MRgFUS. After initial treatment, average TSs improved from 7.4 ± 2.3 at baseline to 0.58 ± 1.1 on day-1 and remained reduced at 2.7 ± 2.4 by year-1. There was an interval of 2.2 ± 1.7 years before patients underwent re-treatment. Following repeat thalamotomy, pre-treatment TSs declined from 5.0 ± 2.6 to 0.23 ± 0.59 on day-1, with improvement sustained at 2.0 ± 1.9 at 1-year resulting in an overall tremor reduction of 75% (p = 0.002). Among patients with 2-year follow-up (n = 5), TSs decreased from 8.8 ± 2.0 preoperatively to 3.0 ± 2.0 2-years after re-treatment (p = 0.003). At 3-months after re-treatment, 81% of patients would undergo the procedure again, indicating patient satisfaction. One-week following the initial and repeat procedures, common SEs included imbalance (initial 65%; repeat 79%), fatigue (61%; 63%), and sensory disturbances (30%; 33%). SE profiles were similar between procedures but imbalance at day-1 (p = 0.01) and fatigue at month-1 (p = 0.05) were significantly more prominent repeat procedures. All SEs were mild (Clavien Dindo Grade I) and majority resolved 3-months post-procedure. CONCLUSIONS: Repeat MRgFUS thalamotomy in patients with recurrent tremor can provide effective and durable tremor control with an acceptable SE profile.
Fields of Study & Subjects
Deep Brain Stimulation and Movement Disorders
Ultrasound and Hyperthermia Applications
Obsessive-Compulsive Spectrum Disorders
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 193–194
- Publication date
- 26 March 2026
- Language
- EN